AGT promotor methylation, which results in reduced or absent AGT expression as shown in cell culture models [135], has been reported in several other tumor types [145,146], but it is not yet known if these relate to tumor responses to O6-alkylating agent therapy [144,147]. The gene discussed is AGT; the disease is neoplasm.